Dr. Gershony graduated from University of Toronto Medical School where he also completed his training in general cardiology. He subsequently completed a fellowship in interventional cardiology at Emory University under Andreas Grüntzig, the inventor of angioplasty. From 1993-1997 he was Director of the Cardiac Cath Lab and Interventional Cardiology at UC Davis. Since 1999 he has practiced interventional cardiology at John Muir Cardiovascular Institute in the Bay Area where he is currently Director of Cardiovascular Research, Education and Technology, and has established a successful TAVR program. Dr. Gershony is board certified in general and interventional cardiology and is a Fellow of the American College of Cardiology, the American Heart Association and the Society for Cardiovascular Angiography and Interventions. He has authored over 100 manuscripts and abstracts in the field of cardiology and is a regularly invited faculty lecturer to the preeminent U.S. and international interventional cardiology conferences.
Dr. Gershony was the Founder of Vascular Solutions (VASC), which had a successful IPO in 2000, and for which he served as CMO and a member of the BOD from 1996-2002. He was the principal inventor of the Duett™ Vascular Sealing Device manufactured by Vascular Solutions.
Dr. Gershony was also the Co-Founder and CMO of AngioScore, which has developed unique scoring balloon catheters for coronary and peripheral angioplasty procedures. He was a member of the senior management team from 2003 until AngioScore’s successful acquisition by Spectranetics (SPNC) in 2014.
Dr. Gershony has served on the adjunct faculty of the Stanford Biodesign Innovation Program. He is the author of 10 issued medical device patents. He has been a member of the scientific advisory board or a consultant to numerous medical device companies and venture capitalists in the Bay Area and elsewhere.